Interestingly, ASPM was previously identified to be expressed at higher levels in secondary GBMs as compared to lower grade astrocytomas [56] and was further validated in another study as one of the six genes with the highest relative expression in GBM compared to pilocytic astrocytomas [57]. The gene discussed is ASPM; the disease is glioblastoma.